Skip to content

A clinical comparison of the six minute walk test to a six minute step test protocol for prescribing ambulatory oxygen.

A clinical comparison of the six minute walk test to a six minute step test protocol for prescribing ambulatory oxygen.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620000345987
Enrollment
61
Registered
2020-03-11
Start date
2019-07-31
Completion date
2020-06-30
Last updated
2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purposes of the study are to compare two clinical tests for ambulatory oxygen in patients who do not automatically qualify for oxygen according to the national recommendations (via Arterial Blood Gas results) but who may physiologically benefit ie. show improved functional capacity and/or blood oxygen saturation levels (SpO2). The two tests are six minute walk test (6MWT) protocol published by the American Thoracic Society (2005 and 2014 update), and our locally developed (and clinically utilized) six minute step test. Subjects are required to complete both tests firstly without oxygen and then repeat the tests with oxygen, as is done clinically when assessing if a patient activity capacity will improve with oxygen supplied. The aim is to compare the tests for outcome similarity, end-of-test SpO2 (as defined by the test protocols), determine which tests the patients preferred, and review the frequency of physician-prescribed ambulatory oxygen from the 2 tests..

Interventions

Brief Name: Ambulatory Oxygen assessments: the Six Minute Walk Test (6MWT) (Arm 1) and a Step Test protocol (Arm 2). What: Arm 1 - Materials for the 6MWT: 30 meter flat walking track (with marks every 1m), two seats, marker cones, High-Vis vests (for patient and tester), cylinder oxygen (c-size, in cylinder trolley as approved by the hospital biomedical engineering department), Oxygen Conserving Device (OCD) set at pulse 4, nasal cannula, stop watch, Oximeter, Modified Borg Scale (10 point

Brief Name: Ambulatory Oxygen assessments: the Six Minute Walk Test (6MWT) (Arm 1) and a Step Test protocol (Arm 2). What: Arm 1 - Materials for the 6MWT: 30 meter flat walking track (with marks every 1m), two seats, marker cones, High-Vis vests (for patient and tester), cylinder oxygen (c-size, in cylinder trolley as approved by the hospital biomedical engineering department), Oxygen Conserving Device (OCD) set at pulse 4, nasal cannula, stop watch, Oximeter, Modified Borg Scale (10 point) for rating perception of breathlessness and leg fatigue, scripted test instructions (international standards ATS 2005 and 2014 update). Arm 2 - Materials for the Step Test: 2-level step apparatus with hand rails (1 meter squared footprint), seat, oxygen delivery cart comprising of a c-size oxygen cylinder and c-size medical air cylinder attached to an oxygen titration device (set at 4 pulsed), nasal cannula, stop watch, Oximeter, Modified Borg Scale (10 point) for rating perception of breathlessness and leg fatigue. Materials for patient: Patient Information Sheet (approved by local HREC), patient consent form (approved by local HREC), patient “Questionnaire” (approved by local HREC). Who provided: Pulmonary Function (PFT) Laboratory staff (ie. the Clinical Medical Scientists) working in the Queen Elizabeth Hospital (TQEH) PFT Lab conduct the patient testing, recruit the patients, and record the patient data as per routine clinical testing protocol for TQEH PFT Laboratory. Each lab staff has a minimum of 3 years undergraduate tertiary education in a relevant science applicable to respiratory medicine, and a minimum of 2 years employment in the TQEH PFT lab. How: All testing is conducted face-to-face with the Medical Scientist and patient, in an individual one-on-one testing context. Arm 1 - 6MWT protocol: 1. The patient is seated for 10 minutes at the 30m-track start line, with the pulse oximeter attached. Oxygen saturations (SpO2), Borg Scale ratings for breathlessness and leg fatigue (resting values, “pre-exercise”) are recorded. 2. Test instructions are given (as per ATS 2005 and 2014-update guidelines). Patient instructed to stand, and stop watch set to 0:00. 3. Patient instructed to begin walking. Test instruction instructions are given at each minute mark (as per ATS 2005 and 2014 guidelines). 4. End of Test: At 6 minutes patient instructed to stop, SpO2 and Borg Scale ratings for breathlessness and leg fatigue (peak exercise values, “post-exercise”) are recorded. (NOTE: patient may stop walking and restart during the 6 minutes exercise period, as many times as they like and for any time duration. Number of stops are recorded.) 5. Patient instructed to sit, resting for 10 minutes minimum (at the 30m-track start line) connected to supplemental oxygen cylinder (nasal cannula, OCD at pulse setting 4). 6. Walk test repeated as above (steps 1-4), with supplemental oxygen (delivered via nasal cannula with OCD on pulse setting 4) in place also, while walking. (Walking aides are permitted as per the patient’s capacity/choice. Specific aides must be recorded and must be used in both repeats of the 6MWT.) Arm 2 - Step Test protocol: 1. The patient is seated for 10 minutes in front of the Step setup, with the pulse oximeter attached and connected to medical air cylinder (nasal cannula, OCD at pulse setting 4). Oxygen saturations (SpO2), Borg Scale ratings for breathlessness and leg fatigue (resting values, “pre-exercise”) are recorded. 2. Test instructions are given (as per TQEH Laboratory Procedures Manual). Patient instructed to stand, and stop watch set to 0:00. 3. Patient instructed to begin stepping. 4. End of Test: At 6 minutes or as soon as the patient wishes to stop/pause stepping (ie. before 6 minutes has passed), the patient is instructed to be seated. Stop time, SpO2 and Borg Scale ratings for breathlessness and leg fatigue (peak exercise values, “post-exercise”) are recorded. Recovery time for SpO2 is recorded (ie. minutes/seconds taken for SpO2 to return to pre-test SpO2 %). 5. Patient instructed to remain seated, resting for 10 minutes minimum (in front of the Step setup) connected to supplemental oxygen cylinder (nasal cannula, OCD at pulse setting 4). 6. Step test repeated as above (steps 1-4), with supplemental oxygen (delivered via nasal cannula with OCD on pulse setting 4) in place also, while stepping and during the recovery (resting) time after stepping has ceased. Where: All testing is conducted within the Pulmonary Function Laboratory at TQEH, on the designated 6MW track (30 meters) and in the designated Exercise Laboratory room (where the stepping apparatus and Oxygen delivery cart are permanently set up). See methods for 6MWT and Step Test for infrastructure outline. When and How much: The 6MWT is conducted as per International Standards (ATS 2005 and 2014 update) on room air (ie no cylinder gases), and then repeated with cylinder oxygen (as described below). There is a 10-30 minutes resting period between repeats. The Step Test is conducted on the placebo gas (cylinder medical air), and repeated on cylinder oxygen, also with a 10-30 minutes resting period between repeats. The 2 ambulatory oxygen assessment tests (6MWT and Step Test) are conducted as either two 30 minute sessions with a week in between (1 session for the 6MWTs and 1 session for the Step Test), or in one longer session (of 60-90 minutes, where both test protocols are performed (as above) on the same day with a minimum of 30 minutes between the 6MWTs and Step Test), as the patient prefers. In both tests, the oxygen is delivered via nasal cannula with a pulsed flow rate set on 4. In the step test, the medical air (placebo) is also delivered via nasal cannula with pulsed flow rate set on 4.

Sponsors

The Queen Elizabeth Hospital
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Crossover
Primary purpose
Diagnosis
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants Participants will be recruited from test referrals sent to the TQEH PFT laboratory for either a 6MWT or a step test (our TQEH laboratory protocol), with the clinical purpose of determining if the patient will benefit from supplemental oxygen while on exertion (or for “home oxygen”). Patients referred for testing for such clinical reasons are referred because they do not meet the national cut of PaO2 less than 55mmHg (as per a recent Arterial Blood Gas (ABG) test) and they do not automatically qualify for oxygen. Inclusion criteria: Patient must have had a recent ABG taken in the days leading up to the appointment (not > 4 weeks before). They must be symptomatically breathless when performing sedentary tasks, such as walking short distances, showering, making the bed, grocery shopping, etc. The patient must have seen a physician regarding the symptoms, and have been assessed as a possible candidate for oxygen therapy. > PaO2 greater than 55mmHg > SOB with low-level exercise > Test referral for either the step test or 6MWT received at TQEH PFT laboratory with clinical questions noted on the referral as: “?benefit of oxygen”, “?home oxygen” or “?desaturation on exercise” (or similar words expressing the same clinical question). > Able to complete both 6MWT and step test as per the current laboratory protocols > Able to comprehend the Borg Scale for perception values

Exclusion criteria

Exclusion criteria: Patient must not already be on exertional oxygen nor have a current oxygen prescription. They must also not have or be: > PaO2 less than 55mmHg > SpO2 less than 85% at rest > Current smoker > Sent for a 6MWT for reasons other than assessment for oxygen (ie. PAH, medication schemes, pulmonary rehabilitation assessment, etc.) > Unable to complete step test requirements during testing > Poor comprehension of test instructions > Poor comprehension of the Borg Scale for perception values > Poor SpO2 oximeter values > Wheelchair or bed bound > Unable to trigger the pulsed Oxygen Conserving Device (OCD) used in the step test > Refusal to complete both or one of the tests > Lab staff or medical staff terminate both or one of the tests early > Adverse events which may include trips, falls, loss of consciousness and arousal of respiratory events

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026